Schroder Investment Management Group Amphastar Pharmaceuticals, Inc. Transaction History

Schroder Investment Management Group

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$27.93 - $31.27 $414,760 - $464,359	-14,850 Reduced 25.09%	44,326 $1.24 Million
Q3 2022 Nov 10, 2022	SELL	$27.56 - $37.75 $12,567 - $17,214	-456 Reduced 0.76%	59,176 $1.66 Million
Q2 2022 Aug 11, 2022	BUY	$29.79 - $42.29 $1.78 Million - $2.52 Million	59,632 New	59,632 $2.04 Million

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.